We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Abstract 9880: Microplastics Exposure Promotes Cardiovascular Disease Risk in Mice
Summary
A mouse study found that microplastic exposure increased risk factors associated with cardiovascular disease, including inflammation and oxidative stress in heart and blood vessel tissue. Mice exposed to microplastics showed changes in cholesterol metabolism and vascular function compared to unexposed mice. This early-stage animal research raises questions about whether microplastic exposure contributes to heart disease risk in humans.
Microplastics (MPs), particles with a diameter less than 5 mm, have become a common and abundant environmental pollutant. Prior studies suggested exposure to MPs induces oxidative stress and inflammation. As these outcomes also underlie cardiovascular disease (CVD), we sought to determine if ingestion of MPs promotes cardiovascular disease risk. Thus we supplied male C57BL/6J mice (13-weeks old, n=10 in each group) with normal drinking water or that containing two sizes of polystyrene (PS) beads (0.5 μm, 5 μm) at two different doses (0.1 μg/ml and 1 μg/ml) for 12 weeks. At intervals throughout this feeding time course and at termination, we measured several indices of pre-clinical CVD. Compared with control mice, we observed a statistically significant increase in body weight in those mice consuming the 0.5 μm polystyrene beads at a dose of 1 μg/ml as early as 3 weeks after initiation of treatment. This statistically significant increase in mice body weight was maintained after 9-(1.85 fold increase versus control group) and 12-weeks (2.02 fold increase versus control group) of consumption. Furthermore, this increase in body weight appeared to be due to an increase in fat mass. Dual-energy X-ray absorptiometry (DEXA) scan analysis showed that the percent body fat significantly increased in PS exposure groups (control: 13.78±0.17% versus 17.24±0.93% in mice consuming 0.5 μm PS particles at a dose of, 1 μg/ml). In the same group of mice, we also observed an increase in fasting blood glucose (1.46 fold), fasting plasma insulin (2.50 fold), and HOMA-IR scores (2.18 fold) after 12 weeks exposure. Consistently, after analysis of a gene expression array, we found altered expression of some genes regulating adipogenesis and white adipose browning in collected perivascular adipose tissue samples. An analysis of the gut microbiome also identified changes consistent with an increase in adiposity. Thus, our results suggest that polystyrene exposure promotes adiposity and insulin resistance and is a heretofore unrecognized risk factor for atherosclerosis development and CVD.
Sign in to start a discussion.
More Papers Like This
Relationship between microplastics and cardiovascular risk factors
This review examines the emerging evidence linking microplastic exposure to cardiovascular risk factors, including endothelial dysfunction, oxidative stress, and inflammation, which are early indicators of heart disease. The authors conclude that microplastics represent a newly recognized environmental cardiovascular risk factor warranting further clinical research.
Microplastics: A Modifiable Cardiac Risk Factor
This review examines the emerging evidence linking microplastic exposure to cardiovascular disease risk factors, including oxidative stress, inflammation, endothelial dysfunction, and thrombosis. The study highlights that micro- and nanoplastics have been identified in coronary artery plaque, suggesting that microplastic exposure may represent a modifiable but currently underrecognized cardiac risk factor.
Cardiotoxicity of Microplastics: An Emerging Cardiovascular Risk Factor
This review examines emerging evidence that microplastics may pose risks to cardiovascular health, summarizing findings from laboratory and animal studies. Researchers found that microplastic exposure has been linked to inflammation, oxidative stress, and disrupted heart function in experimental settings. Given that cardiovascular disease is already the leading cause of death globally, the study suggests that microplastics as a potential contributing factor warrant urgent further investigation.
Microplastics. a New Risk Factor for Atherosclerotic Cardiovascular Disease
This paper reviews emerging evidence linking microplastic exposure to atherosclerotic cardiovascular disease, noting that MPs have been detected in arterial plaques and human tissues and may contribute to cardiovascular risk through inflammation, oxidative stress, and endothelial disruption.
Micro- and nanoplastics: A new cardiovascular risk factor?
This review examines the growing evidence that micro- and nanoplastics may pose risks to the heart and blood vessels. Studies in animals and cell cultures show that these tiny plastic particles can enter the bloodstream, trigger inflammation, promote blood clotting, and damage blood vessel walls. While human data is still limited, the review suggests that micro- and nanoplastic exposure should be considered a potential new risk factor for cardiovascular disease.